S. 2693 (119th)Bill Overview

Biobased Market Expansion Act of 2025

Agriculture and Food|Agriculture and Food
Cosponsors
Support
Bipartisan
Introduced
Sep 3, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill amends section 9002 of the Farm Security and Rural Investment Act of 2002 to expand the Federal biobased markets program. Key changes include stronger federal procurement requirements for biobased products (including an annual increase in biobased-only contracts or volume), establishment of price preferences for biobased products, explicit encouragement to procure biobased products produced wholly or partly in the United States, new reporting and public transparency requirements, mandatory training for procurement staff, updates to federal procurement catalogs to flag eligible biobased products, annual verification by the Office of Federal Procurement Policy, and a Comptroller General review and report to Congress within two years.

Why people may split

Progressives emphasize environmental and rural economic benefits and wants stronger domestic-content and labor/environmental safeguards; conservatives emphasize cost, market distortion, and bureaucratic expansion.

Watch point

Relative to its intended legislative type, this bill is a substantive statutory amendment that adds procurement preferences, reporting, training, catalog updates, verification, and a GAO review to expand federal use of biobased products.

This bill amends section 9002 of the Farm Security and Rural Investment Act of 2002 to expand the Federal biobased markets program.

Key changes include stronger federal procurement requirements for biobased products (including an annual increase in biobased-only contracts or volume), establishment of price preferences for biobased products, explicit encouragement to procure biobased products produced wholly or partly in the United States, new reporting and public transparency requirements, mandatory training for procurement staff, updates to federal procurement catalogs to flag eligible biobased products, annual verification by the Office of Federal Procurement Policy, and a Comptroller General review and report to Congress within two years.

The bill also clarifies some exclusions where biobased items exceed price preferences or conflict with Buy American requirements and requests more detailed data on economic and geographic impacts of biobased production.

Passage40/100

Judged on content alone, the bill is a modest, administratively focused expansion of an existing federal procurement program that is plausibly attractive to constituencies favoring domestic manufacturing and sustainable products. Its lack of major new spending and inclusion of oversight and implementation deadlines improve feasibility. However, the introduction of price preferences and mandatory annual procurement increases creates potential resistance from procurement officials and fiscal watchdogs, and it may need to be folded into a larger package or amended to address cost and interagency concerns to secure final passage.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a substantive statutory amendment that adds procurement preferences, reporting, training, catalog updates, verification, and a GAO review to expand federal use of biobased products. It identifies responsible agencies and includes several concrete timelines and reporting requirements, but leaves important implementation parameters and fiscal provisions unspecified and contains some drafting/formatting irregularities that reduce textual clarity.

Contention60/100

Progressives emphasize environmental and rural economic benefits and wants stronger domestic-content and labor/environmental safeguards; conservatives emphasize cost, market distortion, and bureaucratic expansion.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agencies · StatesTaxpayers · Federal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesIncreased and more predictable federal demand for biobased products could stimulate domestic biomanufacturing and agric…
  • StatesPrice preferences and explicit encouragement to buy biobased products produced in the United States may incentivize ons…
  • Potential benefitStandardized procurement rules, required training, and clearer cataloging of eligible items may reduce procurement fric…
Likely burdened
  • TaxpayersMandated increases in biobased procurement and price preferences could raise government acquisition costs if biobased a…
  • Federal agenciesNew administrative requirements—training, expanded reporting, catalog updates, and annual verification—will impose time…
  • Potential burdenIf domestic supply of certain biobased products is limited, procurement mandates could create acquisition delays, reduc…
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize environmental and rural economic benefits and wants stronger domestic-content and labor/environmental safeguards; conservatives emphasize cost, market distortion, and bureaucratic expansion.
Progressive80%

A mainstream progressive would likely view the bill favorably as a targeted federal policy to expand markets for low‑carbon, renewable, and domestically produced biobased products while supporting rural jobs and manufacturing.

They would appreciate the combination of procurement mandates, promotion of US production, transparency, and training requirements that can build demand for greener materials.

They would also be attentive to whether the policy ensures environmental integrity and benefits small and mid‑sized producers rather than primarily large incumbents.

Leans supportive
Centrist65%

A pragmatic moderate would view the bill as a reasonable, incremental federal policy to expand demand for domestically produced biobased products, with some useful accountability measures (reporting, OFPP verification, GAO review).

They would like to see evidence that procurement changes are cost-effective and administrable without imposing large fiscal burdens or procurement complexity.

Overall, they would be open to supporting it if implementation includes clear metrics, phased timelines, and protections against undue cost increases or conflicts with existing procurement statutes.

Split reaction
Conservative30%

A mainstream conservative would be skeptical of new federal procurement mandates and price preferences that expand government-directed purchasing and could raise costs for taxpayers.

They may welcome the emphasis on domestic production and rural job creation but will be concerned about market distortions, regulatory expansion, and added bureaucracy (training, reporting, verification).

They will favor voluntary or incentive‑based approaches rather than mandates and will scrutinize any implication that the bill overrides or complicates existing Buy American or procurement law.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Judged on content alone, the bill is a modest, administratively focused expansion of an existing federal procurement program that is plausibly attractive to constituencies favoring domestic manufacturing and sustainable products. Its lack of major new spending and inclusion of oversight and implementation deadlines improve feasibility. However, the introduction of price preferences and mandatory annual procurement increases creates potential resistance from procurement officials and fiscal watchdogs, and it may need to be folded into a larger package or amended to address cost and interagency concerns to secure final passage.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • No cost estimate or Congressional Budget Office (CBO) score is included in the bill text; the fiscal impact on acquisition budgets and whether agencies will incur measurable cost increases is unknown.
  • The bill alters interactions with existing procurement law (e.g., Buy American-like provisions); how agencies and legal counsel interpret conflicts or precedence is unclear and could affect implementation and political support.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize environmental and rural economic benefits and wants stronger domestic-content and labor/environmental safeguards; co…

Judged on content alone, the bill is a modest, administratively focused expansion of an existing federal procurement program that is plausi…

Unlocked analysis

Relative to its intended legislative type, this bill is a substantive statutory amendment that adds procurement preferences, reporting, training, catalog updates, verification, and a GAO review to expand federal use of…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis